Page last updated: 2024-08-24

mibefradil and digoxin

mibefradil has been researched along with digoxin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fischer, H; Huwyler, J; Poli, S; Schwab, D; Tabatabaei, A	1
Lombardo, F; Obach, RS; Waters, NJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Kirch, W; Kleinbloesem, C; Siepmann, M	1
Kirch, W; Siepmann, M	1

Trials

1 trial(s) available for mibefradil and digoxin

Article	Year
The interaction of the calcium antagonist RO 40-5967 with digoxin. British journal of clinical pharmacology, 1995, Volume: 39, Issue:5 Topics: Administration, Oral; Adult; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Digoxin; Dose-Response Relationship, Drug; Drug Synergism; Electrocardiography; Fluorescence Polarization; Heart Rate; Humans; Male; Mibefradil; Stroke Volume; Tetrahydronaphthalenes; Ultrasonography, Doppler	1995

Article

Year

The interaction of the calcium antagonist RO 40-5967 with digoxin.

British journal of clinical pharmacology, 1995, Volume: 39, Issue:5

Topics: Administration, Oral; Adult; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Digoxin; Dose-Response Relationship, Drug; Drug Synergism; Electrocardiography; Fluorescence Polarization; Heart Rate; Humans; Male; Mibefradil; Stroke Volume; Tetrahydronaphthalenes; Ultrasonography, Doppler

1995

Other Studies

6 other study(ies) available for mibefradil and digoxin

Article	Year
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. Journal of medicinal chemistry, 2003, Apr-24, Volume: 46, Issue:9 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Mice; Models, Molecular; Rhodamines; Species Specificity; Swine	2003
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Drug-drug interactions of new active substances: mibefradil example. European journal of clinical pharmacology, 2000, Volume: 56, Issue:3 Topics: Digoxin; Drug Interactions; Humans; Mibefradil	2000